Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,975 public trials 742 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Study Of Allergic Rhinitis In Patients Who Also Have Asthma

NCT00296491

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +10 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Glendale, Arizona, United States
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
View all 121 locations
View Trial Details
Completed

Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma.

NCT00600171

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Fresno, California, United States
  • GSK Investigational Site Huntington Beach, California, United States
View all 89 locations
View Trial Details
Completed

A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma

NCT00441441

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Riverside, California, United States
View all 55 locations
View Trial Details
Completed

A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT00606684

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Florence, Alabama, United States
  • GSK Investigational Site Jasper, Alabama, United States
  • GSK Investigational Site Montgomery, Alabama, United States
  • GSK Investigational Site Fullerton, California, United States
View all 99 locations
View Trial Details
Completed

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

NCT01444430

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Huntsville, Alabama, United States
  • Research Site Anchorage, Alaska, United States
  • Research Site Gilbert, Arizona, United States
View all 340 locations
View Trial Details
Completed

Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127)

NCT00313209

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Altana Pharma/Nycomed Investigational Site Linz, Austria
  • Altana Pharma/Nycomed Investigational Site Neusiedl/See, Austria
  • Altana Pharma/Nycomed Investigational Site Perg, Austria
  • Altana Pharma/Nycomed Investigational Site Salzburg, Austria
View all 134 locations
View Trial Details

Related conditions